Physician

Naiara Alvarez, MD

According to 2025 Medicare claims, Naiara Alvarez, MD (NPI: 1578873857) practices rheumatology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is NAIARA M ALVAREZ MD PA (NPI: 1942702089; TIN: 824472878) and primary practice location at 78550-3227. Alvarez is affiliated with the Main Street Rural Health Dogwood ACO LLC (ACO ID: A5421), participating under the MSSP model.

Alvarez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 291 traditional Medicare patients, billed 100,672 HCPCS/CPT codes, and received $789,207 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,950 prescription claims across 1,307 beneficiaries totaling $26,319,931 in drug costs, led by Ultomiris (Ravulizumab-Cwvz). Open Payments data shows 85 records totaling $53,228. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,360 to $789,207. Similarly, Part D prescription costs have moved sharply higher in recent years, from $86,126 to $26,319,931. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	68	124	$9,360
2016	279	644	$39,165
2017	346	1,311	$62,394
2018	238	4,525	$108,145
2019	307	20,804	$335,031
2020	384	35,471	$508,139
2021	558	71,784	$949,216
2022	611	113,860	$1,165,518
2023	517	116,263	$968,409
2024	291	100,672	$789,207

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	215	$86,126
2016	271	1,567	$597,161
2017	501	2,837	$1,567,131
2018	395	2,695	$2,161,259
2019	512	3,539	$3,517,811
2020	883	6,796	$5,271,802
2021	1,634	11,948	$11,933,746
2022	1,654	10,505	$19,413,188
2023	1,405	8,055	$28,717,313
2024	1,307	6,950	$26,319,931

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	66	66	$131
96413	Administration of chemotherapy into vein, 1 hour or less	42	231	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	404	$93
96375	Injection of additional new drug or substance into vein	36	285	$12
96372	Injection of drug or substance under skin or into muscle	89	426	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ultomiris	Ravulizumab-Cwvz	59	2,556	$4,187,945
Krystexxa	Pegloticase	44	1,232	$2,410,760
Enbrel Mini	Etanercept	290	8,288	$2,118,298
Rinvoq	Upadacitinib	270	8,160	$1,693,847
Humira(Cf) Pen	Adalimumab	201	6,272	$1,650,933

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$1,986	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$51,242	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naiara Alvarez, MD?

Tedicare shows public-source Medicare data for Naiara Alvarez, MD (NPI 1578873857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naiara Alvarez, MD have ACO affiliation data?

Naiara Alvarez, MD is shown with ACO affiliation data for Main Street Rural Health Dogwood ACO LLC (MSSP, ACO ID A5421).

What billing organization is linked to Naiara Alvarez, MD?

Naiara Alvarez, MD is linked to NAIARA M ALVAREZ MD PA (billing NPI 1942702089) in the available physician profile data.

Does Naiara Alvarez, MD have Open Payments data?

Naiara Alvarez, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.